Publications

Jeung J, Nguyen A, Martinez J, Zhang L. A Primary Care Group Resilience Intervention Promotes Child and Caregiver Behavioral Health. JMIR pediatrics and parenting. 2025. PMID: 39931025

David Yoonsuk Oh, Deepak Kilari, Christopher Darr, Kevin Kayvan Zarrabi, Jessica E. Hawley, Russell Kent Pachynski, Scott T. Tagawa, Yuanquan Yang, Simon Buetikofer, Qing Xia, Gunhild Von Amsberg. A phase 1b, open-label, multicenter study of xaluritamig in patients with newly diagnosed localized intermediate- or high-risk prostate cancer in the neoadjuvant setting. Journal of Clinical Oncology. 2025. PMID:

Ng DL, Edelweiss M, Kimambo AH, Vuhahula E, Mushi BP, Adegoke O, Goldberg J, Ibrahim PM, Illonga Z, Jackman J, Jamisse L, Van Loon K, Mmbaga EJ. Efforts to strengthen anatomic pathology diagnostic services for cancer in sub-Saharan Africa: a scoping review protocol. BMJ open. 2025. PMID: 39929505

Makker S, Shah NJ, Carlo MI, Kuo F, Hakimi AA, Chen YB, Iyer G, Kotecha RR. Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma. Current oncology (Toronto, Ont.). 2025. PMID: 39996894

Kwon DY, Shah R, Saturno M, Genet S, Kim E, Fu I, Seyidova N, Oleru O, Hecht AC, Jenkins AL, Margetis K, Taub PJ. Optimizing wound healing following lumbar spine surgery. Journal of plastic, reconstructive & aesthetic surgery : JPRAS. 2025. PMID: 39965443

Zarrabi KK, Saxena A, Mouw KW, Koshkin VS, Friedlander T. Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2025. PMID: 39913872

Nguyen HP, An K, Ito Y, Kharbikar BN, Sheng R, Paredes B, Murray E, Pham K, Bruck M, Zhou X, Biellak C, Ushiki A, Nobuhara M, Fong SL, Bernards DA, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Klein JA, Valdiviez L, Fiehn O, Esserman L, Desai TA, Yee SW, Rosenbluth JM, Ahituv N. Implantation of engineered adipocytes suppresses tumor progression in cancer models. Nature biotechnology. 2025. PMID: 39905264

Ko AH, Chao J, Noel MS, Shankaran V, Sohal D, Crow M, Oberstein PE, Scott AJ, McRee AJ, Rocha Lima CMSP, Fong L, Keenan BP, Soto M, Filbert EL, Hsu FJ, Yang X. A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers. Volume 5 of Issue 2 Cancer Research Communications. 2025. PMID: 39907035

Singal AG, Reddy KR, Colombo M, Morris HL, Mospan AR, Cabrera R, Kelley RK, Kilpatrick RD, Trevisani F, Farinati F, Giannini EG, Mehta N, Fried MW, Sangro B, DAA-PASS and ITA.LI.CA Investigators. DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy. Journal of viral hepatitis. 2025. PMID: 39822115

Paciorek A, Mulvey C, McKinley M, Zhang L, Cheng I, Moon F, Le BK, Shih BE, Whitman J, Bergsland E. Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities- A Rigorous Structural Equation Modeling. Journal of the National Comprehensive Cancer Network : JNCCN. 2025. PMID: 39938473

Cloyd JM, Sarna A, Arango MJ, Bates SE, Bhutani MS, Bloomston M, Chung V, Dotan E, Ferrone CR, Gambino PF, Goenka AH, Goodman KA, Hall WA, He J, Hogg ME, Jayaraman S, Kambadakone A, Katz MHG, Khorana AA, Ko AH, Koay EJ, Kooby DA, Krishna SG, Larsson LK, Lee RT, Maitra A, Massarweh NN, Mikhail S, Muzaffar M, O'Reilly EM, Palta M, Petzel MQB, Philip PA, Reyngold M, Santa Mina D, Sohal DPS, Sundaresan TK, Tsai S, Turner KL, Vreeland TJ, Walston S, Washington MK, Williams TM, Wo JY, Snyder RA. Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Volume 160 of Issue 2 JAMA surgery. 2025. PMID: 39630427

Quincy Harris, Jocelin Chen, Joseph McGuire, John Gordan, Huat Chye Lim, Michael Li, Alan P. Venook, Ann C Griffin, Robin Kate Kelley. Prevalence and clinical characteristics of patients with brain metastases at diagnosis with advanced hepatocellular carcinoma in a retrospective registry. Journal of Clinical Oncology. 2025. PMID:

Feng FY, Smith MR, Saad F, Mobadersany P, Tian SK, Yip SSF, Greshock J, Khan N, Yu MK, McCarthy S, Brookman-May SD, Bourla AB, Todorovic T, Yamashita R, Huang HC, Royce TJ, Showalter TN, Griffin J, Mitani A, Esteva A, Small EJ. Digital Pathology-Based Multimodal Artificial Intelligence Scores and Outcomes in a Randomized Phase III Trial in Men With Nonmetastatic Castration-Resistant Prostate Cancer. JCO precision oncology. 2025. PMID: 39889245

Costa LJ, Banerjee R, Mian H, Weisel K, Bal S, Derman BA, Htut MM, Nagarajan C, Rodriguez C, Richter J, Frigault MJ, Ye JC, van de Donk NWCJ, Voorhees PM, Puliafito B, Bahlis N, Popat R, Chng WJ, Ho PJ, Kaur G, Kapoor P, Du J, Schjesvold F, Berdeja J, Einsele H, Cohen AD, Mikhael J, Biru Y, Rajkumar SV, Lin Y, Martin TG, Chari A. International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma. Leukemia. 2025. PMID: 39870767

Thomas S, Roche E, Desai P, Pawlowska N, Bauer D, Gingrich D, Hsu E, Deitchman AN, Aweeka F, Munster PN. Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant. Scientific Reports. 2025. PMID: 39848945

DeMichele A, Dueck AC, Hlauschek D, Martin M, Burstein H, Pfeiler G, Zdenkowski N, Wolff A, Bellet-Ezquerra M, Winer E, Balic M, Miller K, Colleoni M, Lake D, Rubovsky G, Cameron D, Balko J, Singer CF, Nowecki Z, Iwata H, Wolmark N, Parraga KA, Rugo H, Steger GG, Traina T, Werutsky G, Czajkowska D, Metzger O, El-Abed S, Theall KP, Lu RD, O'Brien P, Fesl C, Mayer E, Gnant M. Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]). Breast cancer research : BCR. 2025. PMID: 39849600

Atreya CE, Leach H, Asiimwe E, Bahri N, Le BK, Macaire G, Wood KC, Van Blarigan EL, Lee RT. Integrative Oncology: Incorporating Evidence-Based Approaches for Patients With GI Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2025. PMID: 39841946

Kwon DY, Shamamiam P, Kim E, Genet S, Gyasi A, Gallate Z, Seyidova N, Oleru O, Henderson PW. Pulse Irrigation Reduces Rate of Postoperative Hematoma Following Breast Reduction. Aesthetic plastic surgery. 2025. PMID: 39838127

Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Volume 31 of Issue 4 Nature medicine. 2025. PMID: 39833408

Buckley MW, Balaji Warner A, Brahmer J, Cappelli LC, Sharfman WH, Fuchs E, Kang H, Forde PM, Gladstone DE, Ambinder R, Kelly RJ, Lipson EJ, Gojo I, Lee EJ, Johnson TP, Saidha S, Llinas R, Ostrow LW, Naidoo J, Probasco JC. Immune-related encephalitis after immune checkpoint inhibitor therapy. The oncologist. 2025. PMID: 39066587